Tianshan Wang

Tianshan Wang

ASSOCIATE AT FANGDA PARTNERS Mr. Tianshan Wang is a corporate lawyer based in the Shanghai office of Fangda Partners. He has extensive experience over healthcare related matters, including: representing BeiGene in its secondary offering on the main board of Hong Kong Stock Exchange; representing J.P. Morgan in the initial public offering and listing of Zai Lab on NASDAQ; representing Novartis and AstraZeneca in its granting of exclusive commercialization rights to other pharmaceutical companies; and advising multi-national pharmaceutical corporations including Bayer, AstraZeneca, Mylan, Carestream Dental on their general corporate matters such as FDI, liquidation, merger and division, compliance, sales and distribution.

Tianshan Wang is qualified to practice in the PRC.

ASSOCIATE AT FANGDA PARTNERS Mr. Tianshan Wang is a corporate lawyer based in the Shanghai office of Fangda Partners. He has extensive experience over healthcare related matters, including: representing BeiGene in its secondary offering on the main board of Hong Kong Stock Exchange; representing J.P. Morgan in the initial public offering and listing of Zai Lab on NASDAQ; representing Novartis and AstraZeneca in its granting of exclusive commercialization rights to other pharmaceutical companies; and advising multi-national pharmaceutical corporations including Bayer, AstraZeneca, Mylan, Carestream Dental on their general corporate matters such as FDI, liquidation, merger and division, compliance, sales and distribution.

Tianshan Wang is qualified to practice in the PRC.